Articles by Aaron Gleaton
Aaron Gleaton is a 3L at the American University Washington College of Law, a Note and Comment Editor of the Administrative Law Review, and a Senior Blog Editor for the IP Brief. He is interested in the intersection of pharmaceutical ("pharma") patent law and food and drug law, particularly Hatch-Waxman litigation. Aaron is originally from Charlotte, N.C. and received a B.S. in Biology from the Virginia Military Institute.
The U.S. District Court for the Southern District of Indiana has issued an order prohibiting defendants from selling generic versions of Cymbalta (duloxetine hydrochloride) during the drug’s remaining patent term. The order arises from ongoing litigation in the case Eli Lilly and Co. v. Wockhardt Ltd.
On April 4, 2011, by a vote of 86-0, the Senate confirmed President Obama’s nomination of Jimmie Reyna to serve as the next judge on the U.S. Court of Appeals for the Federal Circuit, despite his lack of patent experience.
Last Friday, an administrative law judge at the U.S. International Trade Commission (USITC) issued a final determination, finding that Apple did not infringe any of Nokia’s mobile phone and electronic device patents. Although this determination …
After the House of Representatives failed to pass patent reform legislation in 2007, the Senate has finally passed the America Invents Act. This new bill will effectively revamp current patent law and move toward harmonizing …
On February 8, 2011, President Obama issued Executive Order 13565, establishing two Intellectual Property Enforcement Advisory Committees. Headed by the recently appointed Intellectual Property Enforcement Coordinator (IPEC), Victoria Espinel, the two committees will consist of …
